Biosyent Inc. (RX) — Capital Reinvestment Ratio
Biosyent Inc. (RX) has a Capital Reinvestment Ratio of 0.09x as of September 2025, meaning it reinvests 0% of its operating cash flow (CA$2.77 Million) in capital expenditures (CA$240.32K). See RX equity financing ratio to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Biosyent Inc. Capital Reinvestment Ratio (2002–2024)
This chart tracks Biosyent Inc.'s Capital Reinvestment Ratio across 18 annual periods. Check Biosyent Inc. (RX) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Biosyent Inc. (2002–2024)
Year-by-year Capital Reinvestment Ratio for Biosyent Inc. from 2002 to 2024. For live market cap and broader valuation context, see RX company net worth.
| Year | Reinvestment Ratio | Operating CF (CAD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.54x | CA$8.66 Million | CA$4.67 Million | ▲ +17.4% |
| 2023 | 0.46x | CA$5.83 Million | CA$2.67 Million | ▲ +337.4% |
| 2022 | 0.10x | CA$4.95 Million | CA$519.32K | ▲ +426.5% |
| 2021 | 0.02x | CA$4.67 Million | CA$93.18K | ▼ -21.2% |
| 2020 | 0.03x | CA$6.89 Million | CA$174.30K | ▼ -83.6% |
| 2019 | 0.15x | CA$4.77 Million | CA$734.13K | ▲ +91.9% |
| 2018 | 0.08x | CA$6.29 Million | CA$504.02K | ▼ -18.1% |
| 2017 | 0.10x | CA$6.55 Million | CA$640.48K | ▲ +6.2% |
| 2016 | 0.09x | CA$4.40 Million | CA$405.46K | ▼ -77.4% |
| 2015 | 0.41x | CA$2.81 Million | CA$1.15 Million | ▲ +1876.3% |
| 2014 | 0.02x | CA$3.64 Million | CA$75.19K | ▼ -66.6% |
| 2013 | 0.06x | CA$2.12 Million | CA$130.96K | ▼ -13.0% |
| 2012 | 0.07x | CA$1.25 Million | CA$88.75K | ▲ +121.4% |
| 2011 | 0.03x | CA$596.08K | CA$19.13K | ▼ -89.8% |
| 2007 | 0.31x | CA$14.25K | CA$4.48K | ▲ +772.4% |
| 2006 | 0.04x | CA$222.26K | CA$8.02K | ▲ +1526.9% |
| 2005 | 0.00x | CA$747.81K | CA$1.66K | ▼ -90.5% |
| 2002 | 0.02x | CA$905.12K | CA$21.14K | — |